ArticleEuropean journal of nuclear medicine and molecular imaging2019
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 59 citations in OpenAlex.
- Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.EBioMedicine · 2020Trial
- Combined PET-CT and VATS biopsy in pleural effusion: diagnostic accuracy, surgical factors, and prognosis-a retrospective study.General thoracic and cardiovascular surgery · 2026Article
- Turning Fluids into Data for Precision Oncology: A Multidisciplinary Tumor Board Approach to Malignant Pleural Effusions.Biomedicines · 2026Review
- Lung Ultrasound for Pleural Effusion in Cancer Patients: Advanced Ultrasound for Pleural Lesions-A Narrative Review.Cancers · 2025Review
- The role ofPeerJ · 2025Article
- Lymph nodes rather than pleural metabolic activity inTranslational lung cancer research · 2024Article
- Diagnosis of malignant body fluids via cancer-universal methylation in cell-free DNA.JCI insight · 2024Article
- Pleural Uptake Patterns inJournal of clinical medicine · 2023Article
- Novel clinical radiomic nomogram method for differentiating malignant from non-malignant pleural effusions.Heliyon · 2023Article
- Malignant pleural effusion diagnosis and therapy.Open life sciences · 2023Review
- Differentiating malignant and benign pleural effusion in patients with lung cancer: anFrontiers in oncology · 2023Article
- Malignant Pleural Effusions: Updates in Diagnosis and Management.Life (Basel, Switzerland) · 2022Review
- Diagnosis and Management of Malignant Pleural Effusion: A Decade in Review.Diagnostics (Basel, Switzerland) · 2022Review
- Can PET/CT be used more effectively in pleural effusion evaluation?Japanese journal of radiology · 2021Article
- Predicting the nature of pleural effusion in patients with lung adenocarcinoma based onEJNMMI research · 2021Article
- Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.Frontiers in oncology · 2021Article
- Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.International journal of general medicine · 2021Article
- Driverless artificial intelligence framework for the identification of malignant pleural effusion.Translational oncology · 2021Article
- Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.Translational lung cancer research · 2020Article
- Comment on: "the FDG PET/CT score" for the diagnosis of malignant pleural effusion.European journal of nuclear medicine and molecular imaging · 2020Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 1 institution in 1 country.
Funding
Abstract
purposeAlthough some parameters of positron emission tomography with
methodsOne prospective derivation cohort of patients with pleural effusions (84 malignant and 115 benign) was used to develop the PET-CT score for the differential diagnosis of malignant pleural effusion. The PET-CT score was then validated in another independent prospective cohort (n = 74).
resultsThe PET-CT parameters developed for discriminating MPE included unilateral lung nodules and/or masses with increased
conclusionsA simple-to-use PET-CT score that uses PET-CT parameters was developed and validated. The PET-CT score can help physicians to differentiate MPE from benign pleural effusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.